LBA-08 * Results of a phase 1b study of the selective BRAF...

Annals of Oncology 2015 / 06 Vol. 26; Iss. suppl 4

LBA-08 * Results of a phase 1b study of the selective BRAF V600 inhibitor encorafenib in combination with cetuximab alone or cetuximab + alpelisib for treatment of patients with advanced BRAF-mutant metastatic colorectal cancer

Elez, E., Schellens, J., van Geel, R., Bendell, J., Spreafico, A., Schuler, M., Yoshino, T., Delord, J.-P., Yamada, Y., Lolkema, M., Faris, J. E., Eskens, F., Sharma, S., Yaeger, R., Lenz, H.-J., Wain
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv262.08
Date:
June, 2015
File:
PDF, 99 KB
english, 2015
Conversion to is in progress
Conversion to is failed